Santagati joins Revlon board
This article was originally published in The Rose Sheet
Executive Summary
Richard J. Santagati has been elected to Revlon Inc.'s board of directors, effective Oct. 28. Most recently president of Merrimack College in Massachusetts (from 1994 to 2008), Santagati has held seats on the boards of directors of several companies and also has served as CEO of tech firm Artel Communications Corporation, partner of investment management firm Lighthouse Capital Inc., CEO of law firm Gaston & Snow and president and CEO of NYNEX Business Information Systems. Santagati's "management experience and experience as a director will provide even greater breadth and depth to our board," President and CEO Alan T. Ennis states
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.